CLS Holdings USA, Inc. Announces Proposed Amendments to Convertible Debentures and Underlying Warrants

LAS VEGAS, Aug. 18, 2022 /CNW/ - CLS Holdings USA, Inc. (OTC-BB:CLSH) (CNSX:CLSH.CN), the ''Company'' or ''CLS'', a diversified cannabis company operating as Cannabis Life Sciences, today announced that a meeting (the "Meeting") of holders (the "Debentureholders") of the 8.0% unsecured convertible debentures due December 12, 2022 (the "Debentures") of CLS USA, Inc. issued pursuant to an indenture dated as of December 12, 2018, as amended pursuant to a supplemental indenture dated as of March 31, 2021 (as the same has otherwise been amended or may be amended, modified, restated, supplemented or replaced from time to time, collectively, the "Indenture") will be held on Thursday, September 15, 2022 at 2:00 p.m. (Toronto time). At the Meeting, the Company will seek the requisite approval by Debentureholders of record on August 11, 2022 of the Amendments (as defined below) to the terms of the Debentures. As more particularly described in the notice of meeting for the Meeting (the "Notice of Meeting"), a copy of which will be available on the Company's profile at www.sedar.com and mailed to Debentureholders in accordance with applicable securities laws, at the Meeting, Debentureholders will be asked to consider and approve extraordinary resolutions to, among other things, amend (the "Amendments"):